股东委托书协议
Regulus Therapeutics(RGLS)今天 04:15
$Regulus Therapeutics(RGLS)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-102883 Act: 34 Size: 1 MB 网页链接
简介:Regulus Therapeutics Inc.成立于2007年9月6日。该公司是一家临床阶段的生物制药公司,致力于发现和开发针对microRNA的一流药物,以治疗具有重大医疗需求的疾病。
今开:2.23 | 昨收:2.22 |
最高:2.31 | 最低:2.09 |
涨停价: | 跌停价: |
总市值:139440985 |
Regulus Therapeutics(RGLS)今天 04:15
$Regulus Therapeutics(RGLS)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-102883 Act: 34 Size: 1 MB 网页链接
Regulus Therapeutics(RGLS)今天 04:15
$Regulus Therapeutics(RGLS)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-102892 Act: 34 Size: 1 MB 网页链接
Regulus Therapeutics(RGLS)04-10 22:15
$Regulus Therapeutics(RGLS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001710 Act: 34 Size: 8 KB 网页链接
Regulus Therapeutics(RGLS)04-10 05:05
$Regulus Therapeutics(RGLS)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-24-090925 Act: 33 Size: 343 KB 网页链接
Regulus Therapeutics(RGLS)03-22 04:25
$Regulus Therapeutics(RGLS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-073858 Act: 34 Size: 203 KB 网页链接
Regulus Therapeutics(RGLS)03-26 04:25
$Regulus Therapeutics(RGLS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-038457 Act: 34 Size: 80 KB 网页链接
Regulus Therapeutics(RGLS)03-23 04:05
$Regulus Therapeutics(RGLS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001694 Act: 34 Size: 105 KB 网页链接
Regulus Therapeutics(RGLS)03-22 04:35
$Regulus Therapeutics(RGLS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-012543 Act: 34 Size: 7 MB 网页链接
Regulus Therapeutics(RGLS)03-19 09:15
$Regulus Therapeutics(RGLS)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-24-000344 Act: 34 Size: 422 KB 网页链接
Regulus Therapeutics(RGLS)03-21 04:35
$Regulus Therapeutics(RGLS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-024390 Act: 34 Size: 75 KB 网页链接
Dinx2022-05-12 01:27
hahababachn2021-12-08 15:00
chuminhua2021-10-14 11:55
10月13日,Regulus Therapeutics公司再次对其管线进行了调整,并将一个新的肾脏疾病候选药物放入高优先级的队列中,希望在经历了一连串的失败和优先级的改变后能有更好的运气。
这家生物技术公司宣布,RGLS8429将成为其新的肾脏疾病候选药物,取代类似的用于常染色体显性多囊肾病(ADPKD)的RG...查看全文
寂寞的搬运工2021-04-17 00:21
寂寞的搬运工2021-03-21 13:07
$Regulus Therapeutics(RGLS)$ 月线图显示横盘4年,底部放量,看能不能涨4倍查看全文
群氓鄙陋2020-07-29 22:45
请问 $Regulus Therapeutics(RGLS)$ 这家公司干什么的?有何值得关注的?查看全文
兔斯基不吃面2020-07-29 22:43
$Regulus Therapeutics(RGLS)$ 床单被套了补点货降低成本,毕竟这么便宜😅查看全文
兔斯基不吃面2020-07-29 22:35
$Regulus Therapeutics(RGLS)$ 量能和换手率在这,下一个高点应该是向3.14$进军,1.74$就是纸糊的查看全文
无记名人氏2020-07-29 22:11
$Regulus Therapeutics(RGLS)$ 卡在+50% 1.2的位置重新突破高点就好了查看全文
兔斯基不吃面2020-07-29 22:00
$Regulus Therapeutics(RGLS)$ 前期高点1.74$今夜放量突破查看全文
$Regulus Therapeutics(RGLS)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-102883 Act: 34 Size: 1 MB 网页链接
$Regulus Therapeutics(RGLS)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-102892 Act: 34 Size: 1 MB 网页链接
$Regulus Therapeutics(RGLS)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001710 Act: 34 Size: 8 KB 网页链接
$Regulus Therapeutics(RGLS)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-24-090925 Act: 33 Size: 343 KB 网页链接
$Regulus Therapeutics(RGLS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-038457 Act: 34 Size: 80 KB 网页链接
$Regulus Therapeutics(RGLS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001694 Act: 34 Size: 105 KB 网页链接
$Regulus Therapeutics(RGLS)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-012543 Act: 34 Size: 7 MB 网页链接
$Regulus Therapeutics(RGLS)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-073858 Act: 34 Size: 203 KB 网页链接
$Regulus Therapeutics(RGLS)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-024390 Act: 34 Size: 75 KB 网页链接
$Regulus Therapeutics(RGLS)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001072613-24-000344 Act: 34 Size: 422 KB 网页链接